An antibody jab by AstraZeneca can prevent and treat Covid-19, a study finds.
In trials, the AZD7442 treatment was effective in preventing severe disease in non-hospitalised patients with mild to moderate coronavirus.
A single shot reduced the risk of severe Covid or death by 50 per cent, compared to a placebo, in people who had been symptomatic for a week or less.
Most of the 903 people in the trial were at high risk of developing severe Covid-19. The treatment is suitable for those who cannot have a regular vaccination, respond poorly to a jab or whose health conditions put them at risk of serious illness.
AstraZeneca has now submitted a request to the US Food and Drug Administration for the jab to be used as a preventative treatment.
Researcher Prof Hugh Montgomery said it could play ‘an important role in combating this devastating pandemic’
How to get your VELOXNEWS newspaper fix
VELOXNEWS newspaper is still available for you to pick up every weekday morning or you can download our app for all your favourite news, features, puzzles… and the exclusive evening edition!
Download the VELOXNEWS newspaper app for free on App Store and Google Play